Contract Manufacturing

Lonza CEO says the CDMO is ‘not in a capacity race’

Wolfgang Wienand said this week that the company is focused on its overall breadth of capabilities, serving customers across scales, regions, and the entire lifecycle.

Oct. 16, 2026

Lonza’s Vacaville site emerges as crown jewel in CDMO’s biologics growth strategy

Oct. 15, 2026

Minnesota Biomanufacturing Services quadruples capacity with new facility

Oct. 14, 2026

CDMOs at CPHI Milan paint picture of ‘healthy’ commercial manufacturing demand

Oct. 12, 2026

Thermo Fisher adds sterile drug product lines, bioprocessing at Massachusetts site

Oct. 8, 2026

Lonza’s Visp site builds on ADC capabilities with integrated ecosystem

Oct. 6, 2026

SK pharmteco pledges more than $200M to expand US small molecule, peptide capacity

Oct. 1, 2026

CDMOs boost API investments in Europe to address demand, supply chain: GlobalData

Sept. 23, 2026

3 ways Thermo Fisher will benefit from US biopharma reshoring: CEO Marc Casper

Sept. 16, 2026